Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Corpowell BV has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being processed by 1 distinct examiner, indicating a narrow scope of current prosecution. The portfolio shows a low volume of active prosecution with only 1 pending office action. This concentration indicates that the company is focusing its current intellectual property efforts on a single biotechnology filing rather than a broad array of applications.
Naghmeh Nina Moazzami is the busiest examiner for the portfolio, holding 1 busiest examiner pending action. The activity is situated in 1 distinct art unit. This concentration in 1 distinct art unit suggests that the company's current intellectual property efforts are focused on a specific biotechnology innovation. Because the total workload is limited to 1 distinct art unit, practitioners can focus their technical arguments on the specific standards of that unit. The fact that Naghmeh Nina Moazzami handles the only 1 pending office action means that the relationship with this examiner is the primary factor in the company's current patent success.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOAZZAMI, NAGHMEH NINA | 1 | 72.0% | +49.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036275 | CREATING A BIOMIMETIC VEGAN VERSION OF COLLAGEN USING PLANT-BASED AMINO ACIDS AND OPTIONAL INDUCTORS TO EMULATE THE BODY'S NATURAL COLLAGEN BUILDING PROCESS FOR NUTRACEUTICAL AND COSMECEUTICAL PURPOSES | MOAZZAMI, NAGHMEH NINA | 43d |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18036275 | CREATING A BIOMIMETIC VEGAN VERSION OF COLLAGEN USING PLANT-BASED AMINO ACIDS AND OPTIONAL INDUCTORS TO EMULATE THE BODY'S NATURAL COLLAGEN BUILDING PROCESS FOR NUTRACEUTICAL AND COSMECEUTICAL PURPOSES | MOAZZAMI, NAGHMEH NINA | 1652 | §103 | Non-Final OA | 43d | Pending | May 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial